{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:04:12Z","timestamp":1778126652164,"version":"3.51.4"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.semcdb.2016.01.025","type":"journal-article","created":{"date-parts":[[2016,1,24]],"date-time":"2016-01-24T09:30:20Z","timestamp":1453627820000},"page":"3-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Tuberous sclerosis\u2014A model for tumour growth"],"prefix":"10.1016","volume":"52","author":[{"given":"Kayleigh M.","family":"Dodd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9209-7561","authenticated-orcid":false,"given":"Elaine A.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcdb.2016.01.025_bib0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jmg.26.1.28","article-title":"Genetic aspects of tuberous sclerosis in the west of Scotland","volume":"26","author":"Sampson","year":"1989","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0015","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"16 T. Consortium","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(01)00332-4","article-title":"The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation","volume":"105","author":"Tapon","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0092-8674(01)00333-6","article-title":"Drosophila Tsc1 Functions with Tsc2 to Antagonize Insulin Signaling in Regulating Cell Growth, Cell Proliferation, and Organ Size","volume":"105","author":"Potter","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0030","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0035","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ncb999","article-title":"Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins","volume":"5","author":"Zhang","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0045","doi-asserted-by":"crossref","unstructured":"S.N. Sehgal, Rapamune (Sirolimus, Rapamycin): An Overview and Mechanism of Action., Ther. Drug Monit. 17 (1995).","DOI":"10.1097\/00007691-199512000-00019"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0055","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1093\/hmg\/ddn192","article-title":"Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1","volume":"17","author":"Rosner","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0060","doi-asserted-by":"crossref","first-page":"pe27","DOI":"10.1126\/scisignal.267pe27","article-title":"New insights into mTOR signaling: mTORC2 and beyond","volume":"2","author":"Alessi","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0065","unstructured":"Andrew R. Tee, Julian R. Sampson, Deb K. Pal, Joseph M. Bateman, The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0070","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1101\/gad.835000","article-title":"Regulation of cellular growth by the Drosophila target of rapamycin dTOR","volume":"14","author":"Zhang","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0075","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1101\/gad.845700","article-title":"Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin","volume":"14","author":"Oldham","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0080","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature03205","article-title":"Regulation of cap-dependent translation by eIF4E inhibitory proteins","volume":"433","author":"Richter","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0085","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/345544a0","article-title":"Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5\u2032 cap","volume":"345","author":"Lazaris-Karatzas","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0090","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1038\/sj.onc.1209888","article-title":"mTOR, translation initiation and cancer","volume":"25","author":"Mamane","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Hsieh","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11083","article-title":"A unifying model for mTORC1-mediated regulation of mRNA translation","volume":"485","author":"Thoreen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.semcdb.2014.09.014","article-title":"The ever-evolving role of mTOR in translation","volume":"36","author":"Fonseca","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/onc.2012.606","article-title":"Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program","volume":"33","author":"Chauvin","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0115","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1038\/sj.onc.1209883","article-title":"Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases","volume":"25","author":"Mayer","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0125","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","article-title":"SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth","volume":"8","author":"Porstmann","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0135","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/MCB.24.1.200-216.2004","article-title":"mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E","volume":"24","author":"Fingar","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0140","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1073\/pnas.93.3.1065","article-title":"Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E","volume":"93","author":"Rousseau","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0145","unstructured":"T.R. Peterson, M., Laplante, E. Van Veen, M. Van Vugt, C.C., Thoreen, D.M. Sabatini, mTORC1 regulates cytokinesis through activation of Rho-ROCK signaling, Arxiv.org. (2015)."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0150","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000658-197203000-00014","article-title":"Anti-angiogenesis: new concept for therapy of solid tumors","volume":"175","author":"Folkman","year":"1972","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1067\/mjd.2002.120530","article-title":"Tuberous sclerosis-associated lesions of the kidney brain, and skin are angiogenic neoplasms","volume":"46","author":"Arbiser","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0160","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9440(10)63843-6","article-title":"Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures","volume":"162","author":"Karbowniczek","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0165","doi-asserted-by":"crossref","first-page":"680s","DOI":"10.1158\/1078-0432.CCR-06-1865","article-title":"The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma","volume":"13","author":"Kaelin","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0170","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0175","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1158\/1078-0432.CCR-08-2057","article-title":"mTOR inhibitor RAD001 (everolimus) has antiangiogenic\/vascular properties distinct from a VEGFR tyrosine kinase inhibitor","volume":"15","author":"Lane","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0180","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/onc.2014.164","article-title":"mTORC1 drives HIF-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3","volume":"34","author":"Dodd","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.gde.2006.12.006","article-title":"Hypoxia-inducible factors: central regulators of the tumor phenotype","volume":"17","author":"Gordan","year":"2007","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0190","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1158\/1535-7163.MCT-14-0768","article-title":"Loss of tuberous sclerosis complex 2 (TSC2) is frequent in hepatocellular carcinoma and predicts response to mTORC1 inhibitor everolimus","volume":"14","author":"Huynh","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0195","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/sj.onc.1202854","article-title":"Mutation of the 9q34 gene TSC1 in sporadic bladder cancer","volume":"18","author":"Hornigold","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0195-70","article-title":"A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer","volume":"9","author":"Kobayashi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0205","doi-asserted-by":"crossref","first-page":"pe24","DOI":"10.1126\/scisignal.267pe24","article-title":"The pharmacology of mTOR inhibition","volume":"2","author":"Guertin","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.semcancer.2009.05.003","article-title":"The angiogenic switch in carcinogenesis","volume":"19","author":"Baeriswyl","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0215","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat. Rev. Cancer."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0225","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0230","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0235","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0240","doi-asserted-by":"crossref","first-page":"e15394","DOI":"10.1371\/journal.pone.0015394","article-title":"The association of AMPK with ULK1 regulates autophagy","volume":"5","author":"Lee","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0245","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4161\/auto.7.7.15491","article-title":"ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding","volume":"7","author":"Dunlop","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0250","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4161\/auto.7.10.16660","article-title":"ULK1 inhibits the kinase activity of mTORC1 and cell proliferation","volume":"7","author":"Jung","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0255","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.1073\/pnas.1104361108","article-title":"Tumorigenesis in tuberous sclerosis complex is autophagy and p62\/sequestosome 1 (SQSTM1)-dependent","volume":"108","author":"Parkhitko","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0260","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1093\/hmg\/ddu101","article-title":"Neuronal Tsc1\/2 complex controls autophagy through AMPK-dependent regulation of ULK1","volume":"23","author":"Di Nardo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0265","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","article-title":"Ragulator-rag complex targets mTORC1 to the lysosomal surface and is necessary for Its activation by amino acids","volume":"141","author":"Sancak","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semcdb.2014.08.006","article-title":"mTOR and autophagy: a dynamic relationship governed by nutrients and energy","volume":"36","author":"Dunlop","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0275","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ncb2822","article-title":"A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS","volume":"15","author":"Zhang","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0280","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cell.2014.01.024","article-title":"Regulation of TORC1 in response to amino acid starvation via Lysosomal recruitment of TSC2","volume":"156","author":"Demetriades","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0285","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ncb3184","article-title":"Proteostasis control by the unfolded protein response","volume":"17","author":"Hetz","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0290","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.molcel.2007.12.023","article-title":"Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis","volume":"29","author":"Ozcan","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0295","doi-asserted-by":"crossref","first-page":"F831","DOI":"10.1152\/ajprenal.00441.2011","article-title":"Human TSC-associated renal angiomyolipoma cells are hypersensitive to ER stress","volume":"303","author":"Siroky","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0300","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1523\/JNEUROSCI.0778-09.2009","article-title":"Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner","volume":"29","author":"Di Nardo","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0305","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tcb.2012.02.006","article-title":"Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling","volume":"22","author":"Appenzeller-Herzog","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-14-0343","article-title":"Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift","volume":"13","author":"Medvetz","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0315","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.molonc.2014.11.005","article-title":"Endoplasmic reticulum stress and cell death in mTORC1-overactive cells is induced by nelfinavir and enhanced by chloroquine","volume":"9","author":"Johnson","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0320","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2741\/s276","article-title":"Targeting endoplasmic reticulum stress for cancer therapy","volume":"4","author":"Schonthal","year":"2012","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0325","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI58709","article-title":"Lymphangioleiomyomatosis\u2014a wolf in sheep's clothing","volume":"122","author":"Henske","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0330","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1164\/rccm.201205-0848OE","article-title":"Lymphangioleiomyomatosis","volume":"186","author":"McCormack","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0335","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","article-title":"Recurrent lymphangiomyomatosis after transplantation","volume":"167","author":"Karbowniczek","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0340","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/35010550","article-title":"The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho","volume":"2","author":"Lamb","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0345","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1165\/rcmb.2005-0374OC","article-title":"Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis","volume":"34","author":"Goncharova","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0350","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/carcin\/bgu327","article-title":"RacGAP1 expression increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer","volume":"36","author":"Imaoka","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0355","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Yu","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0360","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1378\/chest.117.1.25","article-title":"Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis*","volume":"117","author":"Logginidou","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0365","doi-asserted-by":"crossref","first-page":"9461","DOI":"10.1158\/0008-5472.CAN-06-1895","article-title":"Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase ras homologue enriched in brain","volume":"66","author":"Yu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0370","doi-asserted-by":"crossref","first-page":"654698","DOI":"10.1155\/2012\/654698","article-title":"Role of estrogen receptor signaling in breast cancer metastasis","volume":"2012","author":"Saha Roy","year":"2012","journal-title":"Int. J. Breast Cancer."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0375","doi-asserted-by":"crossref","first-page":"23114","DOI":"10.1074\/jbc.M401912200","article-title":"Estrogen-induced smooth muscle cell growth is regulated by tuberin and associated with altered activation of platelet-derived growth factor receptor-\u03b2 and ERK-1\/2","volume":"279","author":"Finlay","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0380","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","article-title":"A mouse model of tuberous sclerosis: neuronal loss of Tsc1causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival","volume":"27","author":"Meikle","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0385","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0390","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S1470-2045(14)70489-9","article-title":"Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study","volume":"15","author":"Franz","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0395","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: A phase 2 trial","volume":"17","author":"Davies","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0400","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfv249","article-title":"Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial","volume":"31","author":"Bissler","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0405","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s13311-015-0359-5","article-title":"Tuberous sclerosis: a new frontier in targeted treatment of autism","volume":"12","author":"Davis","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0410","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.pharep.2014.12.017","article-title":"Role of mTOR inhibitors in epilepsy treatment","volume":"67","author":"Sadowski","year":"2015","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0415","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/2051-5960-2-71","article-title":"Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies","volume":"2","author":"Liu","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0420","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0425","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2010.05.024","article-title":"Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0430","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2013.05.029","article-title":"Role of the mTOR signaling pathway in epilepsy","volume":"332","author":"Meng","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0435","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nm.3824","article-title":"Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy","volume":"21","author":"Lim","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0440","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ng.2329","article-title":"De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly","volume":"44","author":"Lee","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0445","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0450","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1741-7015-11-54","article-title":"Brain functional networks in syndromic and non-syndromic autism: a graph theoretical study of EEG connectivity","volume":"11","author":"Peters","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0455","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.neuron.2014.07.040","article-title":"Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits","volume":"83","author":"Tang","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0460","first-page":"1671","article-title":"Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci","volume":"11","author":"Habuchi","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0465","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.4176","article-title":"TSC1 involvement in bladder cancer: diverse effects and therapeutic implications","volume":"230","author":"Guo","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0470","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ctrv.2014.11.003","article-title":"Emerging therapeutic targets in bladder cancer","volume":"41","author":"Carneiro","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0475","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1464-410X.2012.11720.x","article-title":"Phase II study of everolimus in metastatic urothelial cancer","volume":"112","author":"Milowsky","year":"2013","journal-title":"BJU Int."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0480","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.1226344","article-title":"Genome sequencing identifies a basis for everolimus sensitivity","volume":"338","author":"Iyer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0485","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2014.7189","article-title":"Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the evolve-1 randomized clinical trial","volume":"312","author":"AXM","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0490","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1056\/NEJMoa1403352","article-title":"Response and acquired resistance to everolimus in anaplastic thyroid cancer","volume":"371","author":"Wagle","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0495","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1158\/1078-0432.CCR-13-2345","article-title":"Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy","volume":"20","author":"Voss","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0500","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"9AD","key":"10.1016\/j.semcdb.2016.01.025_bib0505","first-page":"449","article-title":"Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial","volume":"372","author":"Motzer","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0510","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O\u2019Reilly","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0515","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","article-title":"Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition","volume":"65","author":"Sun","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0520","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.onc.1209812","article-title":"Akt regulates nuclear\/cytoplasmic localization of tuberin","volume":"26","author":"Rosner","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.01.025_bib0525","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1158\/1541-7786.MCR-06-0056","article-title":"Tuberin nuclear localization can be regulated by phosphorylation of its carboxyl terminus","volume":"4","author":"York","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0530","doi-asserted-by":"crossref","first-page":"L258","DOI":"10.1152\/ajplung.00354.2005","article-title":"Subcellular distribution of the TSC2 gene product tuberin in human airway smooth muscle cells is driven by multiple localization sequences and is cell-cycle dependent","volume":"292","author":"Clements","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0535","first-page":"429","article-title":"Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model","volume":"56","author":"Tsuchiya","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0540","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1093\/nar\/gku278","article-title":"Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin","volume":"42","author":"Pradhan","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.semcdb.2016.01.025_bib0545","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"N. Engl. J. Med."}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952116300258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952116300258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T20:27:16Z","timestamp":1537043236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952116300258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":109,"alternative-id":["S1084952116300258"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2016.01.025","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberous sclerosis\u2014A model for tumour growth","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2016.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}